Small Interfering RNA Market Players:
- GE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Thermo Scientific
- Arbutus Biopharma
- Sanofi Genzyme
- Sylentis
- Arrowhead Research
- Genecon Biotechnologies
- Silent Therapeutics
- Horizon Discovery
- OPKO Health
- Agios Pharmaceuticals, Inc.
- Novartis
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of the small interfering RNA was over USD 20.62 billion.
The market size for the small interfering RNA is projected to reach USD 77.12 billion by the end of 2036 expanding at a CAGR of 14.1% during the forecast period i.e., between 2027-2036.
The North America small interfering RNA (SiRNA) market is anticipated to capture a 37% share by 2036, driven by increasing healthcare spending and academic R&D initiatives.
Key players in the market include GE, Thermo Scientific, Arbutus Biopharma, Sanofi Genzyme, Sylentis, Arrowhead Research, Genecon Biotechnologies, Silent Therapeutics, Horizon Discovery, OPKO Health, Agios Pharmaceuticals, Inc., Novartis.
